Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Human papillomavirus (HPV) integration is linked to cervical precancer risk. HPV integration testing offers a more specific triage strategy for HPV-positive individuals, potentially reducing unnecessary procedures.
Area Of Science
- Oncology
- Virology
- Molecular Biology
Background
- Cervical cancer is primarily caused by persistent high-risk human papillomavirus (HPV) infections.
- Cervical Intraepithelial Neoplasia (CIN) represents precancerous lesions that can progress to invasive cervical cancer.
- Current screening relies on cytology and HPV testing, with triage strategies needed for HPV-positive cases.
Purpose Of The Study
- To investigate the correlation between HPV integration status and the immediate risk of CIN.
- To evaluate the efficacy of an HPV integration test as a triage strategy for HPV-positive women.
- To compare the performance of HPV integration testing with traditional cytology for CIN diagnosis.
Main Methods
- A prospective, population-based clinical observational study enrolled 4086 women in China.
- Cervical exfoliated cells were collected for HPV testing, cytologic testing, and HPV integration testing.
- HPV integration testing was performed at baseline and during follow-ups for HPV-positive participants.
Main Results
- HPV integration positively correlated with cervical pathology severity (5.0% in normal to 100% in cancer).
- HPV integration showed higher specificity (92.8%) and positive predictive value (36.4%) for CIN3+ compared to cytology (75.5% and 15.2%).
- The HPV integration testing strategy significantly reduced colposcopy referral rates (10.7% vs. 27.3%) and identified a large population with low CIN3+ risk (1.6%).
Conclusions
- HPV integration is a key molecular event in cervical cancer development.
- HPV integration testing demonstrates potential as a superior triage strategy for HPV-positive individuals.
- This approach may improve diagnostic accuracy and reduce unnecessary referrals in cervical cancer screening.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
• Adult screening for blood pressure, cholesterol, and diabetes
• Cancer screenings such as colonoscopies and...